AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...

Thousands of men living with advanced, hormone-sensitive prostate cancer (HSPC) in England and Wales will be able to access ...

Poolbeg Pharma Plc is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy ...

A new report from the Institute for Clinical and Economic Review (ICER) in the US has found that the net prices of newly ...

Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed ...

Roche's Japanese unit Chugai Pharma has reached a deal to buy Renalys Pharma, a company set up to bring therapies developed elsewhere to markets in Asia. Chugai is paying JP 15 billion ($98 million) ...

Johnny Cheng, currently CFO of HUTCHMED, has been named acting CEO following the departure of Dr Weiguo Su due to health ...

Pharma has three choices when it comes to AI for patient experience: Resist it. Try to control patient-led innovation through ...

George Medicines' recently-approved high blood pressure therapy Widaplik could offer a desperately needed new treatment for ...

Takeda has partnered with China's Innovent Biologics for a pair of late-stage cancer therapies, in a deal that includes an ...

The immediate consequences of the disappointing result are a big reduction in workforce at South San Francisco-based Alector, ...

Google says it has made a breakthrough in its quantum computing research with an algorithm that can run calculations 13,000 ...